BALYASNY ASSET MANAGEMENT L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Avalo Therapeutics Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Avalo Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
18,153,388 shares
Disclosed Ownership
439,312 shares
Ownership
2.4%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 06:57:14 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BALYASNY ASSET MANAGEMENT L.P. disclosed 2.4% ownership in Avalo Therapeutics Inc. Common Stock, par value $0.001 per share (AVTX) on 31 Dec 2025."

Quick Takeaways

  • BALYASNY ASSET MANAGEMENT L.P. filed SCHEDULE 13G/A for Avalo Therapeutics Inc. Common Stock, par value $0.001 per share (AVTX).
  • Disclosed ownership: 2.4%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 14 Nov 2025.
  • Current filing was accepted on 17 Feb 2026, 06:57.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 2.4% 439,312 439,312 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self

Sponsored